McKesson, CD&R buy infusion therapy provider Option Care Health in $5.8 billion deal
06/10/2026 13:02
McKesson, CD&R buy infusion therapy provider Option Care Health in $5.8 billion deal Oct 6 (Reuters) - Drug distributor McKesson MCK.N and private equity firm Clayton Dubilier & Rice on Tuesday agreed to buy infusion therapy provider Option Care Health OPCH.O in a deal worth about $5.8 billion.
(Reporting by Sneha S K in Bengaluru; Editing by Maju Samuel)
Recent news on McKesson
See all newsCencora to buy American Oncology Network in $2.4 billion deal (updated)
Cencora to buy American Oncology Network in $2.4 billion deal; shares fall
Brief: Mckesson Corp - Declares QTRLY Dividend Of $0.94 Per Share
Option Care Health jumps on $5.8 billion take-private deal
Brief: Option Care Health Co To Pay Onyx Bidco Llc Termination Fee Of $146 Million If Deal Terminated Under Certain Circumstances